Skip to main content
Clinical Trials/CTRI/2011/09/002018
CTRI/2011/09/002018
Completed
Phase 4

ASSESSMENT OF MUCOSAL IMMUNITY TO POLIOVIRUSES AFTER A SUPPLEMENTALDOSE OF BIVALENT ORAL POLIOVIRUS VACCINE OR INACTIVATED POLIOVIRUSVACCINE IN CHILDREN IN NORTHERN INDIA: A RANDOMIZED TRIA

World health Organization0 sites990 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
World health Organization
Enrollment
990
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy children aged 6 to 11 months 5 to 6 years or 10 to 11years who reside within a
  • relatively short and easily accessible distance within 30 km to the study sites and do not plan to travel away during entire study period of next 2 months

Exclusion Criteria

  • Children with known thrombocytopenia or bleeding disorders
  • children acutely ill or with signs of acute infection like fever of more than 101 F at the time of enrolment
  • residence of more than 30 km from study site or families expecting to be absent during the 60 day study period
  • A diagnosis or suspicion of immunodeficiency disorder either in the participant or in a member of the immediate family will also render the child ineligible for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials